medmix AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CHF 486.6 million compared to CHF 477.1 million a year ago. Net income was CHF 0.3 million compared to CHF 11.6 million a year ago.

Basic earnings per share from continuing operations was CHF 0.01 compared to CHF 0.28 a year ago. Diluted earnings per share from continuing operations was CHF 0.01 compared to CHF 0.28 a year ago.